
# PROJECT_STATUS

---

# DOCUMENT METADATA

Document ID:
DOC-FOUND-006

Version:
3.3

Status:
LOCKED

Authority:
PROJECT GOVERNANCE

Owner:
Project Coordinator

Strategist:
ChatGPT

Implementation:
Claude

Depends On:
PROJECT_ROADMAP.md
LONG_TERM_ROADMAP.md
DOCUMENT_ARCHITECTURE.md

Required By:
All Stable Documents

Last Updated:
2026-08-16

---

# 1. PURPOSE

This document defines the current governance status of the Safe Medical AI System.

It serves as the authoritative executive summary of project progress, architectural maturity, governance health, documentation health, and strategic readiness throughout the complete project lifecycle.

PROJECT_STATUS functions as the primary governance dashboard for the project and shall remain the Single Source of Truth for overall project status.

---

# 2. PROJECT OVERVIEW

Project Name

Safe Medical AI System for Oncology Patient Education

Project Type

Clinical Health Informatics Platform

Primary Objective

To develop a clinically governed, evidence-based Medical AI system capable of delivering safe oncology patient education through standardized knowledge governance, retrieval architecture, response validation, and organizational governance.

Project Status

Active Development

Current Development Stage

Phase 3 Knowledge Population & Clinical Content Development:
CLOSED

Phase 4 Repository & Integration Verification:
CLOSED

PHASE 5 — CLOSED / PASS

Phase 5 Runtime Implementation and Safety Enforcement has been formally
completed.

Completed implementation tasks:
- Task #002 — Implementation Scaffolding
- Task #003 — Retrieval Foundation
- Task #004 — Filesystem Repository Source
- Task #005 — Runtime Evidence Package
- Task #006 — Runtime Integration / GenerationContext
- Task #007 — Generation Boundary
- Task #008 — Validation Boundary
- Task #009 — Safety Enforcement Boundary

Task #009:
- Architecture / Scope B1–B4: APPROVED / LOCKED
- Implementation: COMPLETE
- R1 E2E enforcement refinement: COMPLETE
- Dedicated Task #009 tests: 47 PASS
- Full regression: 287 PASS
- Independent isolated verification: 287 PASS
- git diff --check: PASS
- Task #003–#008 scope verification: PASS
- Technical Acceptance: PASS
- Commit: 0f413c9
- Remote verification: PASS

Phase 5 governance canonical state:
- PHASE_5_IMPLEMENTATION_READINESS_DECISION_RECORD_v12.0.md
- Phase_5_Governance_Consolidated_Decision_Record_v12.0.md

Phase 5 disposition:
CLOSED / PASS

Current Development Stage

Phase 6 — Validation / Stage 2

Phase 6 Architecture / Scope Gate:
LOCKED

Phase 6 Decision Batches:
B01 → B21 — LOCKED

Phase 6 Stage 2:
Track 1 — COMPLETE
Track 2 — CLOSED / PASS
Track 3 — ACTIVE / STRATEGY APPROVED

Current Controlled Step:

Track 3 — Batch 04 Implementation Preparation

Batch 04 Strategy / Scope:
APPROVED

Actual Phase 6 Validation Execution:
NOT STARTED

Execution Authorization:
NOT GRANTED

Clinical Validation Limitation:
MISSING — REQUIRES SOURCE / CLINICAL INPUT

The system is operationally runnable for controlled research,
development, and controlled evaluation use.

This operational runnability does not constitute:
- clinical validation;
- authorization for clinical decision-making;
- clinical deployment authorization.

Human exploratory testing may proceed as development / controlled
evaluation activity, but formal VC-HUMAN validation requires the
approved evaluator package, approved case set, controlled evaluation
criteria, and evidence capture.

Phase 6 Controlled Evaluation State

CER Run #001:
PASS / CLOSED

Webapp Controlled Trial #001:
PASS / CLOSED

Track 1A — Controlled Chat UI Shell:
PASS / CLOSED

Track 1B — CER Integration:
PASS / CLOSED

Track 1C — Controlled Chat UI Usability / Presentation Polish:
PASS / CLOSED

Track 1 — Controlled Chat UI Foundation:
COMPLETE

Human Run Status:
Track 1A — PASS
Track 1B — PASS
Track 1C — PASS

Actual controlled-evaluation coverage:
1 / 239 Population Packages

Current controlled-evaluation population:
PP-0002 — What is Gastric Cancer

Controlled Chat UI:
IMPLEMENTED — PASS / CLOSED

Current endpoint boundary:
PP-0002 + CKO

Current Controlled Chat UI Boundary:
Controlled Research / Development / Controlled Evaluation only.

No change to CER, retrieval, PP resolution, evidence capture,
or 239-case evaluation architecture was introduced by Track 1.

---

# 3. EXECUTIVE SUMMARY

The Safe Medical AI System has successfully completed:

- Project Foundation
- System Architecture
- Clinical Knowledge Architecture
- Knowledge Governance
- Runtime Pipeline Architecture
- Operational Governance
- Executive Governance
- Organizational Governance
- Regulatory Readiness
- Documentation Governance

The project has successfully completed the architectural design phase required before implementation.

Phase 3 and Phase 4 are formally CLOSED.

Phase 3 established the governed clinical knowledge population:
239 Population Packages and 956 canonical Gold artifacts.

Phase 4 verified repository and integration integrity for the governed
Population Package population.

The project has completed Phase 5 — Implementation and Safety Enforcement
with formal CLOSED / PASS disposition.

Phase 5 completed:

- Task #002 — Implementation Scaffolding — CLOSED / PASS
- Task #003 — Retrieval Foundation — CLOSED / PASS
- Task #004 — Filesystem Repository Source — CLOSED / PASS / REMOTE VERIFIED
- Task #005 — Runtime Evidence Package — CLOSED / PASS
- Task #006 — Runtime Integration / GenerationContext — CLOSED / PASS
- Task #007 — Generation Boundary — CLOSED / PASS
- Task #008 — Validation Boundary — CLOSED / PASS
- Task #009 — Safety Enforcement Boundary — CLOSED / PASS

The project is now in Phase 6 — Validation.

Phase 6 Architecture / Scope Gate is LOCKED and Decision Batches
B01 → B21 are LOCKED.

The current controlled activity is Pre-Execution QA / Execution
Readiness Artifact Assembly.

Actual Phase 6 validation execution has NOT STARTED and Execution
Authorization has NOT been granted.

The implemented system is operationally runnable for controlled
research, development, and controlled evaluation use.

Operational runnability does not constitute clinical validation,
authorization for clinical decision-making, or clinical deployment
authorization.

Phase 6 Stage 2 Track 1 has now been completed.

Track 1A established the Controlled Chat UI shell.
Track 1B connected the UI submission path to the existing governed CER
execution path for the fixed PP-0002 + CKO boundary.
Track 1C completed bounded usability and presentation refinement while
preserving the existing /chat and /chat/query contracts and the governed
CER execution boundary.

Phase 6 Stage 2 Track 1 has been completed.

Track 1A established the Controlled Chat UI shell.
Track 1B connected the UI submission path to the existing governed CER
execution path.
Track 1C completed bounded usability and presentation refinement.

Track 2 — Generic Controlled Evaluation Execution has been completed
and formally closed.

Track 2 established the generalized manifest-backed controlled
evaluation execution mechanism for the approved 239-case population,
while preserving the existing governed CER boundary and frozen
clinical knowledge baseline.

Track 2 does not establish substantive LLM-generated chatbot answers.

The post-Track-2 substantive-generation gap has been formally identified:
the current controlled path does not yet demonstrate a substantive,
evidence-grounded chatbot answer through the Chat UI.

Track 3 Strategy / Scope Review has been initiated and Batch 04 has now
been approved.

Batch 04 establishes the approved strategy/scope for the next controlled
capability workstream:

- substantive-answer definition;
- evidence-grounding acceptance;
- end-to-end generation-path acceptance;
- real-provider execution boundary;
- representative-case boundary;
- preservation of safety and validation boundaries;
- Chat UI acceptance;
- evidence traceability;
- verification strategy;
- explicit non-scope.

Track 3 implementation remains subject to the approved Batch 04 scope
and subsequent implementation verification.

No claim of substantive-generation success is made at this stage.


Human exploratory testing may proceed as development / controlled
evaluation activity. Formal VC-HUMAN validation remains a separate
validation activity requiring the approved evaluator package, approved
case set, controlled evaluation criteria, and evidence capture.

VC-CLIN remains deferred as:

MISSING — REQUIRES SOURCE / CLINICAL INPUT

This limitation applies specifically to incomplete gastric case-level
clinical decision and applicable safety validation coverage.


---

# 4. PROJECT PHASE STATUS

## Phase 1

Foundation & System Architecture

Status

Completed

Governance Approval

Approved

Architecture Validation

Passed

---

## Phase 2

Clinical Knowledge Curation

Status

Completed

Governance Approval

Approved

Architecture Validation

Passed

Documentation Validation

Passed

Phase Exit Review

Passed

---

## Phase 3

Knowledge Population & Clinical Content Development

Status

CLOSED

Governance Approval

Approved

Execution Status

Population Wave 1 complete:
PP-0001 → PP-0239

Production Status

239 Population Packages
956 canonical Gold artifacts

Final Git Verification

PASS

Immutable Phase 3 Git Baseline

a838a9423fc3d14c46f8cd176bafed3b691e65c0

Closure Decision

LD-P4-001 — Phase 3 Formal Closure

Current Integration Verification State

Repository and integration verification is delegated to Phase 4.
Phase 3 closure does not constitute repository integration verification
or retrieval-readiness verification.

---

## Phase 4

Repository & Integration Verification

Status

CLOSED

Activation Basis

Phase 3 formally closed under LD-P4-001.

Verification Status Vocabulary

LD-P4-002

Controlled verification states:

PENDING
PASS
FAIL

Objective

Verify deterministic integration of governed Population Packages into the
Clinical Knowledge Repository and establish traceable repository and
integration evidence for downstream retrieval readiness.

Execution Result

Phase 4 verification completed.

Verified Scope

- Population Package registry reconciliation
- Exact repository path resolution
- Four-artifact Gold Package resolution
- Governance metadata verification
- Immutable repository integration evidence
- Layer 3 aggregate verification

Population Scope

PP-0001 → PP-0239

Canonical Gold Artifact Scope

239 Population Packages
×
4 canonical Gold artifacts
=
956 canonical Gold artifacts

Verification Result

PASS

Phase 4 Closure Basis

Phase 4 repository and integration verification evidence was completed,
reviewed, and committed to the repository.

Phase 4 Closing Commit

70067d020420eb1792419bb7d7308da524f0031c

Post-integration archive correction commit

d4c2994e390d746c37276b7d29d0ba57ebae0d53

Layer 3 Aggregate Verification

PASS

Superseded Layer 3 Verification Record v0.1 was archived and replaced
by the controlled v0.2 record.

Phase 4 Closure

FORMALLY CLOSED

Next Phase

Phase 5 — Implementation

---

## Phase 5

System Implementation & Safety Enforcement

Status

CLOSED / PASS

Entry Basis

Phase 3 — Knowledge Population & Clinical Content Development: CLOSED

Phase 4 — Repository & Integration Verification: CLOSED

Completed Tasks

- Task #002 — Implementation Scaffolding — CLOSED / PASS
- Task #003 — Retrieval Foundation — CLOSED / PASS
- Task #004 — Filesystem Repository Source — CLOSED / PASS / REMOTE VERIFIED
- Task #005 — Runtime Evidence Package — CLOSED / PASS
- Task #006 — Runtime Integration / GenerationContext — CLOSED / PASS
- Task #007 — Generation Boundary — CLOSED / PASS
- Task #008 — Validation Boundary — CLOSED / PASS
- Task #009 — Safety Enforcement Boundary — CLOSED / PASS

Task #009 Technical Acceptance

- Architecture / Scope B1–B4 — APPROVED / LOCKED
- R1 E2E enforcement refinement — COMPLETE
- Dedicated tests — 47 PASS
- Full regression — 287 PASS
- Independent isolated verification — 287 PASS
- git diff --check — PASS
- Task #003–#008 scope verification — PASS
- Technical Acceptance — PASS
- Commit — 0f413c9
- Remote verification — PASS

Phase 5 Governance Canonical State

- PHASE_5_IMPLEMENTATION_READINESS_DECISION_RECORD_v12.0.md
- Phase_5_Governance_Consolidated_Decision_Record_v12.0.md

Phase 5 Closure Disposition

CLOSED / PASS

Phase 5 implementation and safety-enforcement boundary are complete.
No further Phase 5 implementation task remains open.

Next Phase

Phase 6 — Validation

Phase 6 begins with an Architecture / Scope Gate before validation
execution.


---
## Phase 6

Validation

Status

STAGE 2 — TRACK 3 ACTIVE

Architecture / Scope Gate

LOCKED

Decision Batches

B01 → B21 — LOCKED

Phase 6 Stage 2

Track 1A — PASS / CLOSED
Track 1B — PASS / CLOSED
Track 1C — PASS / CLOSED
Track 1 — COMPLETE

Track 2 — Generic Controlled Evaluation Execution
PASS / CLOSED

Track 3 — Substantive Evidence-Grounded Chatbot Capability
ACTIVE — STRATEGY / SCOPE APPROVED

Current Controlled Step

Track 3 — Batch 04 Implementation Preparation

Batch 04

Strategy / Scope — APPROVED

Approved Batch 04 Scope

- Substantive-answer definition
- Evidence-grounding requirement
- End-to-end generation-path acceptance
- Real-provider execution boundary
- Representative-case boundary
- Safety / validation boundary preservation
- Chat UI acceptance
- Evidence traceability
- Verification strategy
- Explicit non-scope

Track 3 Success Condition

The Controlled Chat UI must demonstrate a real substantive answer
grounded in the approved clinical knowledge path while remaining within
the existing governed boundaries.

Track 3 does not succeed merely because:

- an LLM SDK is installed;
- an API call succeeds;
- a provider is connected;
- a generation function returns text.

Current Controlled Evaluation Coverage

1 / 239 Population Packages

Approved Evaluation Mechanism Representation

239 / 239

Human Browser Evidence

1 / 239

Formal Validation

NOT STARTED

Execution Authorization

NOT GRANTED

Operational Boundary

Research / Development / Controlled Evaluation Only

No-Overclaim Boundary

Not Clinically Validated or Authorized for Clinical Decision-Making.

Actual Validation Execution

NOT STARTED

Execution Authorization

NOT GRANTED

VC-TECH

Prepare for Pre-Execution QA

VC-SAFE

Prepare for Pre-Execution QA

VC-HUMAN

Prepare subject to evaluator-package and approved-case-set readiness

VC-SYS

Prepare for Pre-Execution QA

VC-CLIN

DEFERRED — MISSING — REQUIRES SOURCE / CLINICAL INPUT

Operational Boundary

Operationally Runnable — Controlled Research / Development /
Controlled Evaluation Use

No-Overclaim Boundary

Research / Development / Controlled Evaluation Only —
Not Clinically Validated or Authorized for Clinical Decision-Making.


---

## Phase 7

Continuous Evolution

Status

Planned

---

# 5. PROJECT PROGRESS

Estimated overall project progress

Phase 1

100%

Phase 2

100%

Phase 3

100% — CLOSED

Phase 4

100% — CLOSED

Layers 4A, 4B, 4C and 4D completed.

Layer 3 Aggregate Verification completed.

Phase 4 Exit Review / Closing Note completed.

Phase 5

100% — CLOSED / PASS

All approved Phase 5 implementation tasks (#002–#009) completed.

Phase 5 closure is evidenced by approved governance records, technical
acceptance, controlled commits, regression testing, and remote verification.

Phase 6

0% — FORMAL VALIDATION NOT STARTED
Phase 6 Stage 2 Track 1

COMPLETE — Controlled Chat UI Foundation

This milestone does not represent formal Phase 6 validation completion.

Phase 7

0%

Overall Project Progress

Phase-based percentage is not recalculated during Phase 4 verification.

The project has completed its governed architecture, clinical knowledge
population, repository/integration verification, and Phase 5 runtime
implementation and safety-enforcement work.

The project is now preparing for Phase 6 — Validation.

---

# 6. STABLE DOCUMENT STATUS

## Foundation

7 Stable Documents

Status

Complete

---

## System Architecture

7 Stable Documents

Status

Complete

---

## Clinical Knowledge Architecture

5 Stable Documents

Status

Complete

---

## Knowledge Governance

4 Stable Documents

Status

Complete

---

## Runtime Pipeline

4 Stable Documents

Status

Complete

---

## Operational Governance

7 Stable Documents

Status

Complete

---

## Executive Governance

3 Stable Documents

Status

Complete

---

## Organizational Governance

4 Stable Documents

Status

Complete

---

## Regulatory Readiness

1 Stable Document

Status

Complete

---

## Documentation Governance

1 Stable Document

Status

Complete

---

## Strategic Planning

1 Stable Document

Status

Complete

---

## Repository Total

Total Stable Documents

52

Project Status

Architecture Repository Complete

---

# 7. LOCKED DECISION STATUS

Current Locked Decision Range

LD-0010 → LD-0425

Decision Status

Integrated

Governance Status

Locked

Traceability Status

Complete

All approved decisions have been incorporated into the Stable Documentation Repository.

---

# 8. ARCHITECTURE HEALTH

Architecture Completeness

Complete

Architecture Consistency

Validated

Dependency Validation

Passed

Single Source of Truth

Validated

Governance Coverage

Complete

Technology Independence

Maintained

Overall Architecture Health

Excellent

---

# 9. GOVERNANCE HEALTH

Governance Structure

Complete

Governance Layers

Complete

Governance Traceability

Validated

Governance Authority

Defined

Governance Ownership

Defined

Governance Maturity

Architecture Complete

Overall Governance Health

Excellent

---

# 10. DOCUMENTATION HEALTH

Documentation Coverage

Complete

Metadata Compliance

Validated

Versioning

Validated

Traceability

Validated

Documentation Governance

Implemented

Stable Document Registry

Complete

Documentation Quality

Excellent

---

# 11. REPOSITORY HEALTH

Repository Organization

Excellent

Architecture Consistency

Excellent

Document Relationships

Validated

Dependency Integrity

Validated

Maintainability

Excellent

Scalability

Excellent

Repository Readiness

Phase 4 Repository & Integration Verification completed.

Repository Integration Verification

PASS

Aggregate Verification

PASS

Repository Closeout

COMPLETED

Current Repository State

Phase 3 CLOSED
Phase 4 CLOSED
Phase 5 CLOSED / PASS

Authoritative Phase 6 Implementation Branch

phase6/execution-campaign-001

Current Phase 6 implementation state

Track 1A — PASS / CLOSED
Track 1B — PASS / CLOSED
Track 1C — PASS / CLOSED

Track 1 — COMPLETE

Current controlled-evaluation boundary

PP-0002 + CKO

Current controlled-evaluation coverage

1 / 239 Population Packages


---

# 12. CURRENT PROJECT POSITION

Current Phase

Phase 6 — Validation

Current Status

Phase 3 — CLOSED
Phase 4 — CLOSED / PASS
Phase 5 — CLOSED / PASS
Phase 6 — VALIDATION / STAGE 2 — TRACK 1 COMPLETE

Phase 6 Governance

Architecture / Scope Gate — LOCKED
Decision Batches B01 → B21 — LOCKED

Execution Campaign

COMPLETED / REMOTE VERIFIED — PASS
Remote-Verified Commit — 261d3b22a18ebe293fffcf6f8c464fb988c4f652

Phase 6 Stage 2 Track 1

Track 1A — PASS / CLOSED
Track 1B — PASS / CLOSED
Track 1C — PASS / CLOSED

Track 1 — COMPLETE

Human Run

Track 1A — PASS
Track 1B — PASS
Track 1C — PASS

Remaining Phase 6 Stage 2 Objectives

- Controlled evaluation coverage expansion
  1 / 239 → 239 / 239
- Track 2 implementation according to approved scope

CONTROLLED EVALUATION

Completed Controlled Milestones

- CER Run #001 — PASS / CLOSED
- Webapp Controlled Trial #001 — PASS / CLOSED

Current Controlled Evaluation Coverage

1 / 239 Population Packages

Current Controlled Evaluation Population

PP-0002 — What is Gastric Cancer

Current Controlled Evaluation Boundary

PP-0002 + CKO

Remaining Phase 6 Stage 2 Objectives

- Controlled Chat UI
- Controlled evaluation coverage for all 239 Population Packages

Formal Validation Status

NOT STARTED

Execution Authorization

NOT GRANTED

---

# 13. PHASE 2 EXIT REVIEW

Phase 2 underwent comprehensive governance validation prior to closure.

Validation Areas

- Architecture Completeness
- Dependency Validation
- Documentation Validation
- Governance Validation
- Lifecycle Coverage
- Repository Validation

Results

Architecture Completeness

PASS

Dependency Integrity

PASS

Documentation Governance

PASS

Single Source of Truth

PASS

Governance Coverage

PASS

Technology Independence

PASS

Overall Result

PHASE 2 VALIDATION PASSED

---

# 14. PHASE EXIT DECISION

Governance Authority Decision

Phase 2 Approved for Closure

Decision Status

Approved

Architecture Status

Complete

Repository Status

Validated

Transition Authorization

Approved

The project is formally authorized to transition into Phase 3.

---

# 15. MAJOR DELIVERABLES

## Phase 1 Deliverables

Completed

- Foundation Architecture
- System Architecture
- Clinical Navigation Architecture
- Medical Governance
- Knowledge Base Architecture
- Safety Framework
- Prompting Strategy

Status

Complete

---

## Phase 2 Deliverables

Completed

### Clinical Knowledge Architecture

- Knowledge Ingestion Workflow
- Knowledge Object Specification
- Knowledge Passport
- Clinical Knowledge Domains
- Knowledge Relationship Model

### Knowledge Governance

- Knowledge Source Registry
- Knowledge Source Approval Policy
- Knowledge Update Policy
- Retrieval Policy

### Runtime Pipeline

- Evidence Package Specification
- Response Generation Architecture
- Output Validation Framework
- Delivery Policy

### Operational Governance

- System Evaluation Framework
- Monitoring Framework
- Observability Framework
- Incident Management Policy
- Release Policy
- Continuous Improvement Framework
- Quality Management Framework

### Executive Governance

- Governance Dashboard
- Governance Metrics Framework
- Executive Reporting

### Organizational Governance

- Audit Framework
- Governance Maturity Model
- Organizational Governance
- Risk Management Framework

### Regulatory Readiness

- Regulatory Readiness Framework

### Documentation Governance

- Documentation Governance Framework

### Strategic Planning

- Long-term Roadmap

Status

Complete

---

# 16. REPOSITORY SUMMARY

The documentation repository now contains a complete governance architecture supporting:

- project governance
- system architecture
- clinical knowledge architecture
- knowledge governance
- runtime governance
- operational governance
- executive governance
- organizational governance
- regulatory readiness
- strategic planning

The repository functions as the authoritative organizational knowledge base for the Safe Medical AI System.

---

# 17. CURRENT RISKS

- Current architectural risks

No blocking architectural risks identified at Phase 5 closure.

- Current governance risks

No blocking governance risks identified.

- Current documentation risks

No blocking documentation risk identified.

- Current implementation risks

No blocking implementation risk identified at Phase 5 closure.

- Inherited repository finding

PP-0045 and PP-0123 contain byte-identical PRIMARY_EVIDENCE_PACKAGE.md
and QA_REPORT.md files. This requires semantic review before being
classified as a repository defect.

- Phase 6 execution-readiness risk

Phase 6 Architecture / Scope Gate and Decision Batches B01 → B21 are
LOCKED.

Validation execution has not yet started because Pre-Execution QA /
Execution Readiness Artifact Assembly remains the current controlled
step.

Execution Authorization remains NOT GRANTED.

- Phase 6 clinical validation coverage risk

Gastric case-level clinical decision and applicable safety validation
remain deferred because sufficient governed clinical source/case input
is unavailable.

This limitation does not block validatable technical, safety,
human-oversight, or system-level preparation/execution where their
required evidence basis exists.

It does prevent claims of clinical validation or authorization for
clinical decision-making within the affected scope.

- Phase 6 Stage 2 controlled-evaluation coverage risk

Track 1 establishes the Controlled Chat UI foundation but does not
expand the controlled-evaluation population beyond the currently
evidenced PP-0002 boundary.

Current coverage remains:

1 / 239 Population Packages.

Track 2 must expand the evaluation mechanism under explicit scope,
governance, reproducibility, and evidence-capture controls.

---

# 18. CURRENT PRIORITIES

Immediate Priority

Advance Phase 6 Stage 2 Track 3 from approved Strategy / Scope into
controlled implementation preparation.

Completed Stage 2 Milestones

- Track 1 — Controlled Chat UI Foundation — COMPLETE
- Track 2 — Generic Controlled Evaluation Execution — CLOSED / PASS

Current Track 3 Objective

Demonstrate the minimum governed vertical slice required to transform
the current deterministic controlled chatbot response into a substantive,
evidence-grounded chatbot answer through the existing Chat UI.

Approved Batch 04 Scope

- define substantive answer acceptance;
- establish evidence-grounding acceptance;
- establish end-to-end generation-path acceptance;
- establish the real-provider execution boundary;
- establish a representative-case boundary;
- preserve existing safety and validation boundaries;
- establish Chat UI acceptance;
- establish evidence traceability;
- establish verification requirements;
- explicitly prevent Track 4 or unrelated scope expansion.

Current Constraints

- preserve the completed Track 1 UI;
- preserve the generalized Track 2 controlled-evaluation mechanism;
- preserve the governed CER boundary;
- preserve the frozen clinical knowledge baseline;
- preserve the Research / Development / Controlled Evaluation boundary;
- do not claim 239 / 239 human execution;
- do not claim formal validation;
- do not introduce Track 4 scope;
- do not create an open-ended remediation or QA loop.

No Track 3 implementation result is claimed until implementation and
verification are completed.

---

# 19. PHASE 3 READINESS

Architecture Readiness

Ready

Governance Readiness

Ready

Documentation Readiness

Ready

Knowledge Governance

Ready

Operational Governance

Ready

Organizational Governance

Ready

Regulatory Readiness

Ready

Phase 3 Production Readiness

CLOSED

Phase 3 Closure

LOCKED — LD-P4-001

---

# 20. LONG-TERM VISION

The Safe Medical AI System aims to become:

- a clinically governed Medical AI platform
- an evidence-based oncology education system
- a reusable governance architecture
- a scalable clinical knowledge platform
- a high-quality Health Informatics research portfolio
- a future-ready clinical AI ecosystem

Long-term development shall remain guided by governance, patient safety, and continuous organizational learning.

---

# 21. PROJECT MILESTONES

Completed Milestones

- Foundation Established
- Governance Model Established
- System Architecture Completed
- Clinical Knowledge Architecture Completed
- Runtime Architecture Completed
- Operational Governance Completed
- Executive Governance Completed
- Organizational Governance Completed
- Regulatory Readiness Completed
- Documentation Governance Completed
- Phase 2 Successfully Closed
- Population Wave 1 completed
- Phase 3 formally closed under LD-P4-001
- Layer 4A — Registry Integration — PASS
- Layer 4B — Repository Resolution — PASS
- Layer 4C — Governance Metadata — PASS
- Layer 4D — Immutable Integration Evidence — evidence assembled; final repository binding PASS
- Layer 3 Aggregate Verification — PASS
- Phase 4 Exit Review — completed
- Completed Phase-4 Repository Integration and Verification Layers: PASS
- Phase 4 Closing Note completed
- Superseded Layer 3 v0.1 verification record archived

Phase 5 Closure Milestones

- Task #002 — Implementation Scaffolding — PASS
- Task #003 — Retrieval Foundation — PASS
- Task #004 — Filesystem Repository Source — PASS / REMOTE VERIFIED
- Task #005 — Runtime Evidence Package — PASS
- Task #006 — Runtime Integration / GenerationContext — PASS
- Task #007 — Generation Boundary — PASS
- Task #008 — Validation Boundary — PASS
- Task #009 — Safety Enforcement Boundary — PASS
- Phase 5 Technical Acceptance — PASS
- Phase 5 Remote Verification — PASS
- Phase 5 Formal Closure — CLOSED / PASS

Phase 6 Controlled Evaluation Milestones

- CER Run #001 — PASS / CLOSED
- Webapp Controlled Trial #001 — PASS / CLOSED
- Real local HTTP execution through POST /cer/evaluate — PASS
- Controlled evaluation evidence captured and committed
- Current controlled-evaluation coverage established as 1 / 239 PP

Phase 6 Stage 2 — Track 1 Milestones

- Track 1A — Controlled Chat UI Shell — PASS / CLOSED
- Track 1A Human Run — PASS
- Track 1B — CER Integration — PASS / CLOSED
- Track 1B Human Verification — PASS
- Track 1C — Controlled Chat UI Usability / Presentation Polish —
  PASS / CLOSED
- Track 1C Human Run — PASS
- Track 1 — Controlled Chat UI Foundation — COMPLETE
- Track 1 Closeout / Reconciliation — COMPLETE

Phase 6 Stage 2 — Track 2 Milestones

- Track 2 — Generic Controlled Evaluation Execution — PASS / CLOSED
- Track 2 Closing Commit — 0b74b2d
- Approved evaluation mechanism representation — 239 / 239
- Human browser evidence — 1 / 239
- Human-verified sample — EC-0003 → PP-0003

Phase 6 Stage 2 — Track 3

- Track 3 Strategy / Scope Review — ACTIVE
- Batch 04 Strategy / Scope — APPROVED
- Substantive evidence-grounded generation capability — NOT YET IMPLEMENTED

Next Phase 6 Stage 2 Objective

Track 3 — Implement and verify the approved substantive,
evidence-grounded chatbot vertical slice.

---

# 22. RELATED DOCUMENTS

## Core Governance

- PROJECT_FOUNDATION.md
- PROJECT_ROADMAP.md
- LONG_TERM_ROADMAP.md

## Documentation

- DOCUMENT_ARCHITECTURE.md
- DOCUMENTATION_GOVERNANCE_FRAMEWORK.md

## Organizational Governance

- ORGANIZATIONAL_GOVERNANCE.md
- QUALITY_MANAGEMENT_FRAMEWORK.md

---

# 23. AMENDMENT TRACEABILITY

## Version 1.0

Initial project status established during Foundation.

---

## Version 1.1

Updated following completion of Phase 1.

---

## Version 2.0

Major project consolidation following successful completion of Phase 2.

Major updates include:

- Complete project status review
- Architecture health assessment
- Governance health assessment
- Documentation health assessment
- Repository health assessment
- Stable Document statistics
- Phase 2 Exit Review
- Phase Exit Approval
- Phase 3 Readiness Assessment
- Repository consolidation
- Long-term strategic alignment

Integrated Locked Decisions

LD-0010 → LD-0380

Version 2.0 supersedes Version 1.1 and becomes the authoritative project status document for the Safe Medical AI System.

## Version 2.1

Updated following completion of the Knowledge Population Framework.

Major updates include:

- Phase 3 execution officially initiated
- Knowledge Population Framework completed
- Repository expanded to 52 Stable Documents
- Locked Decision Range updated to LD-0425
- Population Wave 1 established as the current execution stage

Integrated Locked Decisions

LD-0381 → LD-0425

## Version 2.2

Updated following continued execution of Population Wave 1.

Major updates include:

- Phase 3 status updated from initiated to active execution.
- Population Wave 1 status updated to active execution.
- Population Package production workflow validated.
- Source-First execution model formally recognized.
- User-Controlled Population Package Sequence formally recognized.
- Immediate four-artifact Gold ZIP production formally recognized.
- Mandatory Boundary declaration formally recognized.
- Mandatory adjacent Population Package overlap check formally recognized.
- Latest completed Population Package updated to PP-0167.
- Next Population Package remains unassigned until explicitly requested by the Project Coordinator.

Integrated execution state:

Population Wave 1 — Active


## Version  v2.3

Update:

Latest completed PP → PP-0189
Population Wave 1 → active
Gold workflow → validated through PP-0189
Source-First → validated
User-Controlled Sequence → validated
Absolute Gold Depth rule → validated
Current execution model → updated
Current QA gate → PASS — GOLD — READY FOR INTEGRATION
Next PP → Not assigned / awaiting explicit Project Coordinator request

Không cần major version.

## Version 2.5

Updated following formal closure of Phase 3 and activation of Phase 4.

Major updates include:

- Phase 3 formally closed under LD-P4-001.
- Final direct Git verification accepted as PASS.
- Immutable Phase 3 Git baseline recorded:
  a838a9423fc3d14c46f8cd176bafed3b691e65c0.
- Population Wave 1 confirmed complete:
  PP-0001 → PP-0239.
- Canonical Gold artifact baseline confirmed:
  239 × 4 = 956.
- Phase 4 activated as Repository & Integration Verification.
- Phase 4 verification status vocabulary locked under LD-P4-002.
- Repository integration and retrieval-readiness verification delegated to Phase 4.
- No system release or Git milestone tag created at Phase 3 closure.

Integrated Locked Decisions

LD-P4-001
LD-P4-002

## Version 2.6

Updated following formal closure of Phase 4 — Repository & Integration
Verification.

Major updates include:

- Phase 4 formally closed.
- Layers 4A, 4B, 4C and 4D recorded as completed.
- Layer 3 Aggregate Verification recorded as PASS.
- Phase 4 closing commit recorded:
  70067d020420eb1792419bb7d7308da524f0031c.
- Post-integration archive correction commit recorded:
  d4c2994e390d746c37276b7d29d0ba57ebae0d53.
- Superseded Layer 3 Verification Record v0.1 archived.
- Current project position advanced to Phase 5 — Implementation.
- Phase 4 evidence and repository closeout formally recognized.

No major architectural restructuring introduced.

## Version 2.7

Updated following Task #004 closeout and Phase 5 thread handover.

Major updates include:

- Phase 5 status advanced from PLANNED to ACTIVE.
- Task #002 implementation scaffolding recorded as CLOSED / PASS.
- Task #003 retrieval foundation recorded as CLOSED / PASS.
- Task #004 filesystem repository source recorded as CLOSED / PASS / REMOTE VERIFIED.
- Authoritative Phase 5 branch recorded:
  phase5/task002-scaffolding.
- Current remote implementation HEAD recorded:
  c28b498b6f13066253940291bdcbc6ed3f2f4e2c.
- Current implementation boundary clarified as:
  Repository → Population/PP → canonical Gold artifacts.
- Task #005 Architecture/Scope Gate established as the next controlled milestone.
- Runtime Evidence Package boundary explicitly identified as unresolved and
  not to be inferred by implementation.

No major architectural restructuring introduced.

## Version 2.9

Updated following approval and locking of Phase 6 Decision Batches
B20 → B21 and transition into Pre-Execution QA preparation.

Major updates include:

- Phase 6 Architecture / Scope Gate recorded as LOCKED.
- Decision Batches B01 → B21 recorded as LOCKED.
- Phase 6 state advanced from execution preparation planning to
  Pre-Execution QA / execution-readiness preparation.
- Operationally Runnable status explicitly distinguished from
  clinical validation and authorization for clinical decision-making.
- Controlled Research / Development / Controlled Evaluation boundary
  explicitly recorded.
- Human exploratory testing distinguished from formal VC-HUMAN
  validation.
- VC-CLIN gastric case-level validation retained as:
  MISSING — REQUIRES SOURCE / CLINICAL INPUT.
- Actual validation execution recorded as NOT STARTED.
- Execution authorization recorded as NOT GRANTED.
- Current priorities updated from Architecture / Scope Gate definition
  to Pre-Execution QA / Execution Readiness Artifact Assembly.

## Version 3.0

Updated following completion of CER Run #001 and Webapp Controlled
Trial #001.

Major updates include:

- CER Run #001 recorded as PASS / CLOSED.
- Webapp Controlled Trial #001 recorded as PASS / CLOSED.
- Real local HTTP execution through POST /cer/evaluate recorded.
- Current controlled-evaluation coverage recorded as 1 / 239 PP.
- PP-0002 — What is Gastric Cancer recorded as the only PP currently
  supported by actual controlled-evaluation evidence.
- Current endpoint boundary recorded as PP-0002 + CKO.
- Phase 6 Stage 2 objective recorded as Controlled Chat UI plus
  controlled evaluation of all 239 Population Packages.
- Formal Phase 6 validation remains NOT STARTED.
- Phase 7 scope remains unchanged.

## Version 3.1

Updated following completion and closeout of Phase 6 Stage 2 Track 1.

Major updates include:

- Track 1A — Controlled Chat UI Shell recorded as PASS / CLOSED.
- Track 1B — CER Integration recorded as PASS / CLOSED.
- Track 1C — Controlled Chat UI Usability / Presentation Polish
  recorded as PASS / CLOSED.
- Track 1 human-run verification recorded as PASS across Track 1A,
  Track 1B, and Track 1C.
- Controlled Chat UI Foundation recorded as COMPLETE.
- Current controlled-evaluation coverage remains 1 / 239 Population
  Packages.
- PP-0002 + CKO remains the current controlled-evaluation boundary.
- Formal Phase 6 validation remains NOT STARTED.
- Track 2 established as the next Phase 6 Stage 2 controlled activity.
- Research / Development / Controlled Evaluation no-overclaim boundary
  preserved.

No major architectural restructuring introduced.

## Version 3.3

Updated following approval of Phase 6 Stage 2 Track 3 Batch 04
Strategy / Scope.

Major updates include:

- Track 2 — Generic Controlled Evaluation Execution recorded as
  PASS / CLOSED.
- Track 3 recorded as the current Phase 6 Stage 2 workstream.
- Batch 04 Strategy / Scope recorded as APPROVED.
- The substantive evidence-grounded chatbot capability identified as
  the current controlled capability gap.
- Approved Batch 04 scope recorded, including:
  substantive-answer definition, evidence grounding, end-to-end
  generation acceptance, real-provider boundary, representative-case
  boundary, safety/validation preservation, Chat UI acceptance,
  traceability, verification strategy, and explicit non-scope.
- Track 3 implementation explicitly remains pending implementation
  and verification.
- Formal Phase 6 validation remains NOT STARTED.
- Execution Authorization remains NOT GRANTED.
- Human evidence remains 1 / 239.
- Approved evaluation mechanism representation remains 239 / 239.

No Track 4 scope introduced.
No clinical validation claim introduced.
No change to the frozen clinical knowledge baseline.

---

# 24. PROJECT STATUS SUMMARY

Current Phase

Phase 6 — Validation

Architecture Status

Complete

Governance Status

Complete

Documentation Status

Phase 6 execution-readiness documentation active

Knowledge Population

Phase 3 CLOSED

Repository / Integration Verification

Phase 4 CLOSED / PASS

Implementation

Phase 5 CLOSED / PASS

Phase 6 Governance

Architecture / Scope Gate — LOCKED
B01 → B21 — LOCKED

Phase 6 Current State

EXECUTION PREPARATION — PARTIALLY READY

Actual Validation Execution

NOT STARTED

Execution Authorization

NOT GRANTED

VC-CLIN

DEFERRED — MISSING — REQUIRES SOURCE / CLINICAL INPUT

Operational System Boundary

Operationally Runnable — Controlled Research / Development /
Controlled Evaluation Use

No-Overclaim Boundary

Research / Development / Controlled Evaluation Only —
Not Clinically Validated or Authorized for Clinical Decision-Making.

Next Controlled Step

Track 3 — Batch 04 Implementation Preparation

Current Track 3 State

Strategy / Scope — APPROVED

Substantive Generation State

NOT YET IMPLEMENTED

Formal Validation

NOT STARTED

Execution Authorization

NOT GRANTED

Controlled Evaluation Mechanism Representation

239 / 239

Human Evidence Coverage

1 / 239

No-Overclaim Boundary

Research / Development / Controlled Evaluation Only —
Not Clinically Validated or Authorized for Clinical Decision-Making.